April 13, 2009 - SenoRx Inc. released an additional model of its SenoSonix System.
Like the original SenoSonix, the new model is an integration of SenoRx's EnCor breast biopsy system with ultrasound imaging. This new version of the device incorporates a microminiaturization ultrasound technology that combines personal computing power and flexibility. The new ultrasound component is designed, developed and manufactured by Terason.
This versatile ultrasound technology coupled with SenoRx's proprietary EnCor vacuum-assisted biopsy technology reportedly results in an attractive alternative model of the SenoSonix System. The modular design and sophisticated imaging architecture are now available in a reduced footprint with increased portability.
The SenoSonix System received 510(k) clearance in October 2007 and CE Mark approval in April 2008.
"Our new SenoSonix model is designed to meet the needs of breast surgeons performing breast biopsy procedures utilizing ultrasound in both their offices and in the hospital surgery suite who wish to have the flexibility of moving the ultrasound component between the two locations," said Lloyd Malchow, SenoRx president and CEO. "The new system may be particularly well suited for markets in Europe and Asia where a significant percentage of biopsy procedures are performed utilizing ultrasound.”
For more information: www.senorx.com
February 18, 2026 
